SKU:  PME100099     Target:  EGFR

Price: 10μg $82.00; 50μg $320.00 ; 100 μg $480.00

SKU:  PME-M100062     Target:  EGFR

Price: 10μg $103.00 ; 50μg $388.00 ; 100 μg $568.00

SKU:  PME-C100036     Target:  EGFR

Price:10μg $120.00; 50μg $380.00; 100μg $570.00


Posts found

Going Nuclear: The Boom of Radiopharmaceutical Targets in 2024

In 2024, the radiopharmaceutical sector has seen a flurry of activity in mergers and acquisitions. [...]

HER3/ERBB3: Dominating Cancer Therapy with ADCs and Beyond

On September 17, a collaboration between Daiichi Sankyo and Merck announced that patritumab deruxtecan, a [...]

Emerging Trends: ADC Drug Targets to Watch at ASCO 2024

The 2024 American Society of Clinical Oncology Annual Meeting (ASCO 2024) will take place in [...]

Immune Checkpoint B7-H3: Exploring the Current Landscape of Targeted Therapies

In December 2023, GlaxoSmithKline (“GSK”) invested $1.71 billion to obtain the global exclusive rights for [...]

GPR75 – An Emerging Target for Weight Loss Drugs

When it comes to weight loss medications, one cannot overlook the remarkable success of Semaglutide [...]

MUC1 – What is its Potential in Cancer Therapy?

Mucin1 (MUC1), also known as MAM6 and EMA, is a surface mucin glycoprotein found to [...]

Can AXL Break Through in Tumor Immunotherapy with Setbacks in AXL-ADC?

At the end of 2020, Genmab and ADC Therapeutics announced the termination of clinical development [...]

Unraveling the Mystery of ‘Million-Dollar’ CAR-T Therapy

In 2012, a young girl named Emily Whitehead, suffering from acute lymphoblastic leukemia, became the [...]


Pages found